DMARD DISRUPTION, INCREASED DISEASE ACTIVITY, and PROLONGED SYMPTOM DURATION after ACUTE COVID-19 among PATIENTS with RHEUMATIC DISEASE: A PROSPECTIVE STUDY

Di Iorio, M.; Cook, C.; Vanni, K.; Patel, N.; D'Silva, K.; Fu, X.; Wang, J.; Prisco, L.; Kowalski, E.; Zaccardelli, A.; Martin, L.; Qian, G.; Hsu, T.; Wallace, Z.; Sparks, J.

Di Iorio, M.; Cook, C.; Vanni, K.; Patel, N.; D'Silva, K.; Fu, X.; Wang, J.; Prisco, L.; Kowalski, E.; Zaccardelli, A.; Martin, L.; Qian, G.; Hsu, T.; Wallace, Z.; Sparks, J..

Annals of the Rheumatic Diseases ; 81:949-950, 2022.

Article in English | EMBASE | ID: covidwho-2008979

Keywords

disease modifying antirheumatic drug; hydroxychloroquine; rituximab; adult; clinical feature; complication; conference abstract; controlled study; coronavirus disease 2019; demographics; fatigue; female; functional status; health care system; human; major clinical study; male; Massachusetts; middle aged; pain; prospective study; quality of life; rheumatic disease; Routine Assessment of Patient Index Data; survivor

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Language: English Journal: Annals of the Rheumatic Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google